Continued benefit from paclitaxel-eluting compared with bare-metal stent implantation in saphenous vein graft lesions during long-term follow-up of the SOS (Stenting of Saphenous Vein Grafts) trial

JACC: Cardiovascular Interventions

Volumn 4, Issue 2, 2011, Pages 176-182

  Brilakis, Emmanouil S ^a,b   Lichtenwalter, Christopher ^a,b   Abdel Karim, Abdul Rahman R ^a,b   De Lemos, James A ^a,b   Obel, Owen ^a,b   Addo, Tayo ^a,b   Roesle, Michele ^a   Haagen, Donald ^a   Rangan, Bavana V ^a   Saeed, Bilal ^d   Bissett, Joseph K ^e   Sachdeva, Rajesh ^e   Voudris, Vassilios V ^f   Karyofillis, Panagiotis ^f   Kar, Biswajit ^c   Rossen, James ^g   Fasseas, Panayotis ^h   Berger, Peter ⁱ   Banerjee, Subhash ^a,b  

^a Veterans Affairs North Texas Health Care System   (United States)

^b UNIVERSITY OF TEXAS AT DALLAS   (United States)

^c MICHAEL E DEBAKEY VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d MEDICAL COLLEGE OF OHIO   (United States)

^e CENTRAL ARKANSAS VETERANS HEALTHCARE SYSTEM   (United States)

^f ONASSIS CARDIAC SURGERY CENTER   (Greece)

^g VETERANS AFFAIRS MEDICAL CENTER   (United States)

^h MEDICAL COLLEGE OF WISCONSIN   (United States)

ⁱ GEISINGER MEDICAL CENTER   (United States)

Author keywords

bare metal stent(s); coronary artery bypass graft surgery; drug eluting stent(s); outcomes; percutaneous coronary intervention; saphenous vein grafts

Indexed keywords

PACLITAXEL;

ACUTE CORONARY SYNDROME; AGED; ARTICLE; BARE METAL STENT; DRUG ELUTING STENT; FOLLOW UP; HAZARD RATIO; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REVASCULARIZATION; SAPHENOUS VEIN GRAFT; STABLE ANGINA PECTORIS; STENT THROMBOSIS;

AGED; ANGIOPLASTY, BALLOON, CORONARY; CARDIOVASCULAR AGENTS; CORONARY ANGIOGRAPHY; CORONARY ARTERY BYPASS; DRUG-ELUTING STENTS; FEMALE; GRAFT OCCLUSION, VASCULAR; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; METALS; MIDDLE AGED; MYOCARDIAL INFARCTION; PACLITAXEL; PROPORTIONAL HAZARDS MODELS; PROSTHESIS DESIGN; RISK ASSESSMENT; RISK FACTORS; SAPHENOUS VEIN; SINGLE-BLIND METHOD; STENTS; THROMBOSIS; TIME FACTORS; TREATMENT OUTCOME; UNITED STATES;

EID: 79951999985     PISSN: 19368798     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcin.2010.10.003     Document Type: Article

References (38)

1. E.S. Brilakis, B. Saeed, and S. Banerjee Drug-eluting stents in saphenous vein graft interventions: a systematic review EuroIntervention 5 2010 722 730
2. P. Vermeersch, P. Agostoni, and S. Verheye Randomized double-blind comparison of sirolimus-eluting stent versus bare-metal stent implantation in diseased saphenous vein grafts: six-month angiographic, intravasc (Pubitemid 44895571)
3. P. Vermeersch, P. Agostoni, S. Verheye DELAYED RRISC Investigators Increased late mortality after sirolimus-eluting stents versus bare-metal stents in diseased saphenous vein grafts: results from the randomized DELAYED RRISC trial J Am Coll Cardiol 50 2007 261 267 (Pubitemid 47039289)
4. E.S. Brilakis, C. Lichtenwalter, and J.A. de Lemos A randomized controlled trial of a paclitaxel-eluting stent versus a similar bare-metal stent in saphenous vein graft lesions the SOS (Stenting of Saphenous Vein Grafts) trial J Am Coll Cardiol 53 2009 919 928
5. C. Lichtenwalter, J.A. de Lemos, and M. Roesle Clinical presentation and angiographic characteristics of saphenous vein graft failure after stenting: insights from the SOS (Stenting of Saphenous Vein Grafts) trial J Am Coll Cardiol Intv 2 2009 855 860
6. N. Badhey, C. Lichtenwalter, and J.A. de Lemos Contemporary use of embolic protection devices in saphenous vein graft interventions: insights from the Stenting of Saphenous Vein Grafts trial Catheter Cardiovasc Interv 76 2010 263 269
7. D.E. Cutlip, S. Windecker, R. Mehran Academic Research Consortium Clinical end points in coronary stent trials: a case for standardized definitions Circulation 115 2007 2344 2351 (Pubitemid 46685903)
8. M.S. Lee, T. Yang, D.E. Kandzari, J.M. Tobis, H. Liao, and E. Mahmud Comparison by meta-analysis of drug-eluting stents and bare metal stents for saphenous vein graft intervention Am J Cardiol 105 2010 1076 1082
9. P. Meier, E.S. Brilakis, R. Conti, G. Knapp, M.H. Shishehbor, and H.S. Gurm Drug-eluting versus bare-metal stent for treatment of saphenous vein grafts: a meta-analysis PloS One 5 2010 e11040
10. D. Joyal, K.B. Filion, and M.J. Eisenberg Effectiveness and safety of drug-eluting stents in vein grafts: a meta-analysis Am Heart J 159 2010 15969e4
11. A. Sanchez-Recalde, S.J. Valero, and R. Moreno Safety and efficacy of drug-eluting stents versus bare-metal stents in saphenous vein grafts lesions: a meta-analysis EuroIntervention 6 2010 149 160
12. L. Testa, P. Agostoni, and P. Vermeersch Drug eluting stent versus bare metal stent in the treatment of saphenous vein graft disease a systematic review and meta-analysis EuroIntervention 6 2010 527 536
13. J. Rodes-Cabau, O.F. Bertrand, and E. Larose Comparison of plaque sealing with paclitaxel-eluting stents versus medical therapy for the treatment of moderate nonsignificant saphenous vein graft lesions: the moderate vein graft lesion stenting with the Taxus stent and intravascular ultrasound (VELETI) pilot trial Circulation 120 2009 1978 1986
14. R.M. Minutello, S. Bhagan, and A. Sharma Long-term clinical benefit of sirolimus-eluting stents compared to bare metal stents in the treatment of saphenous vein graft disease J Interv Cardiol 20 2007 458 465 (Pubitemid 350179467)
15. D. Bansal, R. Muppidi, and S. Singla Percutaneous intervention on the saphenous vein bypass grafts: long-term outcomes Catheter Cardiovasc Interv 71 2008 58 61 (Pubitemid 351158347)
16. G. Gioia, A. Benassi, R. Mohendra, K. Chowdhury, I. Masood, and W. Matthai Lack of clinical long-term benefit with the use of a drug eluting stent compared to use of a bare metal stent in saphenous vein grafts Catheter Cardiovasc Interv 72 2008 13 20 (Pubitemid 352008974)
17. R.K. Ramana, A. Ronan, and K. Cohoon Long-term clinical outcomes of real-world experience using sirolimus-eluting stents in saphenous vein graft disease Catheter Cardiovasc Interv 71 2008 886 893 (Pubitemid 351951305)
18. R.J. Applegate, M. Sacrinty, M. Kutcher, R. Santos, S. Gandhi, and W. Little Late outcomes of drug-eluting versus bare metal stents in saphenous vein grafts: propensity score analysis Catheter Cardiovasc Interv 72 2008 7 12 (Pubitemid 352013502)
19. A. Assali, Y. Raz, and H. Vaknin-Assa Beneficial 2-years results of drug-eluting stents in saphenous vein graft lesions EuroIntervention 4 2008 108 114
20. P.H. van Twisk, J. Daemen, N. Kukreja, R.T. van Domburg, and P.W. Serruys Four-year safety and efficacy of the unrestricted use of sirolimus- and paclitaxel-eluting stents in coronary artery bypass grafts EuroIntervention 4 2008 311 317
21. J.C. Guo, M. Xu, G.Z. Wang, and C.S. Ma Late lumen loss of drug eluting stents versus bare mental stents for saphenous vein graft intervention J Clin Rehabilitative Tissues Eng Res 12 2008 6971 6975
22. I. Lozano, T. Garcia-Camarero, and P. Carrillo Comparison of drug-eluting and bare metal stents in saphenous vein grafts Immediate and long-term results Rev Esp Cardiol 62 2009 39 47
23. M.H. Shishehbor, R. Hawi, and I.M. Singh Drug-eluting versus bare-metal stents for treating saphenous vein grafts Am Heart J 158 2009 637 643
24. N.J. Goswami, M. Gaffigan, and G. Berrio Long-term outcomes of drug-eluting stents versus bare-metal stents in saphenous vein graft disease: results from the Prairie "Real World" Stent Registry Catheter Cardiovasc Interv 75 2009 93 100
25. B.R. Brodie, H. Wilson, T. Stuckey STENT Group Outcomes with drug-eluting versus bare-metal stents in saphenous vein graft intervention: results from the STENT (Strategic Transcatheter Evaluation of New Therapies) Group J Am Coll Cardiol Intv 2 2009 1105 1112
26. A. Latib, L. Ferri, and A. Ielasi Comparison of the long-term safety and efficacy of drug-eluting and bare-metal stent implantation in saphenous vein grafts Circ Cardiovasc Interv 3 2010 249 256
27. D.E. Baldwin, J.D. Abbott, and J.C. Trost Comparison of drug-eluting and bare metal stents for saphenous vein graft lesions (from the National Heart, Lung, and Blood Institute Dynamic Registry) Am J Cardiol 106 2010 946 951
28. R.V. Jeger, S. Schneiter, C. Kaiser BASKET Investigators Drug-eluting stents compared with bare metal stents improve late outcome after saphenous vein graft but not after large native vessel interventions Cardiology 112 2008 49 55
29. S.G. Ellis "Crying fire in a theater" or a "confirmatory sighting?" J Am Coll Cardiol 50 2007 268 269
30. S.G. Ellis, D. Kandzari, and D.J. Kereiakes Utility of sirolimus-eluting Cypher stents to reduce 12-month target vessel revascularization in saphenous vein graft stenoses: results of a multicenter 350-patient case-control study J Invasive Cardiol 19 2007 404 409 (Pubitemid 47509462)
31. E.S. Brilakis, J.M. Lasala, and D.A. Cox Outcomes after implantation of the Taxus paclitaxel-eluting stent in saphenous vein graft lesions: results from the ARRIVE (TAXUS Peri-Approval Registry: A Multicenter Safety Surveillance) program J Am Coll Cardiol Intv 3 2010 742 750
32. M.S. Lee, P.P. Hu, and J. Aragon Comparison of sirolimus-eluting stents with paclitaxel-eluting stents in saphenous vein graft intervention (from a Multicenter Southern California Registry) Am J Cardiol 106 2010 337 341
33. W.W. Chu, P.K. Kuchulakanti, and B. Wang Efficacy of sirolimus-eluting stents as compared to paclitaxel-eluting stents for saphenous vein graft intervention J Interv Cardiol 19 2006 121 125
34. S. Gormez, R. Erdim, and O. Erdogmus Treatment of saphenous vein graft lesions with paclitaxel- and sirolimus-eluting stents: comparison of short- and long-term clinical outcomes Anadolu Kardiyol Derg 8 2008 431 436
35. E.S. Brilakis, and S. Banerjee Could paclitaxel-eluting stents be superior to sirolimus-eluting stents for the treatment of saphenous vein graft lesions? Am J Cardiol 106 2010 1367 1368
36. R.H. Mehta, E. Honeycutt, and E.D. Peterson Impact of internal mammary artery conduit on long-term outcomes after percutaneous intervention of saphenous vein graft Circulation 114 2006 I396 I401
37. I. Varghese, J. Samuel, S. Banerjee, and E.S. Brilakis Comparison of percutaneous coronary intervention in native coronary arteries vs. bypass grafts in patients with prior coronary artery bypass graft surgery Cardiovasc Revasc Med 10 2009 103 109
38. E.S. Brilakis, T.Y. Wang, and S.V. Rao Frequency and predictors of drug-eluting stent use in saphenous vein bypass graft percutaneous coronary interventions: a report from the American College of Cardiology National Cardiovascular Data CathPCI registry J Am Coll Cardiol Intv 3 2010 1068 1073